Malignant Germ Cell–Like Tumors, Expressing Ki-1 Antigen (CD30), Are Revealed during in Vivo Differentiation of Partially Reprogrammed Human-Induced Pluripotent Stem Cells

The American Journal of Pathology,

The oncogenicity of therapeutically valuable patient–specific induced pluripotent stem cells–derived cells should be scrupulously evaluated before they are used for any clinical applications.

Print Article Summary